1. To the extent authorized by federal law, a pharmacist who registers with the Board to engage in the activity authorized by this section may, in accordance with the requirements of the protocol prescribed pursuant to subsection 2:
(a) Assess a patient to determine whether:
(1) The patient has an opioid use disorder; and
(2) Medication-assisted treatment would be appropriate for the patient;
(b) Counsel and provide information to the patient concerning evidence-based treatment for opioid use disorders, including, without limitation, medication-assisted treatment; and
(c) Prescribe and dispense a drug for medication-assisted treatment.
2. The Board shall adopt regulations:
(a) Prescribing the requirements to register with the Board to engage in the activity authorized by this section; and
(b) Establishing a protocol for the actions authorized by this section.
3. As used in this section, “medication-assisted treatment” means treatment for an opioid use disorder using medication approved by the United States Food and Drug Administration for that purpose.